Marijuana receives Cannabinoid Medicinals global marketing rights
Under the contract, Hemp will have exclusive worldwide marketing rights for 3 years and non-exclusive marketing rights for 20 years to products derived from cannabis or hemp and
AstraZeneca and Sino Biopharmaceutical’s subsidiary Chia Tai Tianqing Pharmaceutical Group (CTTQ) have signed an exclusive licence agreement for TQC3721.